LP
CBPO

LMR Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

LMR Partners’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,970
Closed -$1.26K – 632
2016
Q1 		$1.26K Buy
+10,970
New +$1.29M 0.14% 144

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LMR Partners's CBPO Position: Q2 2016 in Review

LMR Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 10,970 shares — an estimated $1.26K sold.

LMR Partners first reported a position in CBPO in Q1 2016 and held it in 1 quarter. The position peaked at $1.26K in Q1 2016. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

  • LMR Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • LMR Partners sold 10,970 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $1.26K.
  • LMR Partners first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 1 quarter.
  • LMR Partners's China Biologic Products Holdings, Inc. position peaked at $1.26K in Q1 2016.
  • 138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on LMR Partners's 13F filing for Q2 2016, filed 28 Jul 2016.